Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells.
Autor: | Karaman O; Department of Chemistry, Middle East Technical University (METU), 06800, Ankara, Turkey., Almammadov T; Department of Chemistry, Koc University, 34450, Istanbul, Turkey., Emre Gedik M; Department of Basic Oncology, Hacettepe University, 06100, Ankara, Turkey., Gunaydin G; Department of Basic Oncology, Hacettepe University, 06100, Ankara, Turkey., Kolemen S; Department of Chemistry, Koc University, 34450, Istanbul, Turkey.; Koc University (KU), Surface Science and Technology Center (KUYTAM), 34450, Istanbul, Turkey., Gunbas G; Department of Chemistry, Middle East Technical University (METU), 06800, Ankara, Turkey. |
---|---|
Jazyk: | angličtina |
Zdroj: | ChemMedChem [ChemMedChem] 2019 Nov 20; Vol. 14 (22), pp. 1879-1886. Date of Electronic Publication: 2019 Nov 05. |
DOI: | 10.1002/cmdc.201900380 |
Abstrakt: | Two red-absorbing, water-soluble and mitochondria (MT)-targeting selenophene-substituted BODIPY-based photosensitizers (PSs) were realized (BOD-Se, BOD-Se-I), and their potential as photodynamic therapy (PDT) agents were evaluated. BOD-Se-I showed higher 1 O (© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.) |
Databáze: | MEDLINE |
Externí odkaz: |